TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.44$ -2.2% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 7.7 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VXRT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.3 -9.6 -14 -10 -15 -13 -24 -60 -95 -70 -45 7.7
2.4 1.1 0.1 0.4 3.2 3.6 2.7 4.2 5.8 8.6 8.9 8.6
1.7 2.1 2.0 0.5 0.5 0.6 4.4 8.9 14 14 12 8.3
20 2.0 1.9 -0.4 -4.2 0.8 4.4 12 18 – – –
3.6 -12 9.1 0.9 2.5 1.3 2.8 -2.1 -4.7 -11 3.3 -23
0.1 0.1 0.2 0.1 0.7 0.9 1.2 5.2 9.6 1.9 0.6 0.1
-10 -19 1.3 3.2 26 -0.9 -1.2 -49 -20 44 -21 17
0.0 0.0 0.0 – – – – – – – – –
0.0 7.5 0.0 0.0 0.0 2.5 138 3.6 17 -0.4 0.3 –
-0.1 -0.3 -0.4 -1.7 -1.7 3.8 – 0.0 – – – –
27 -0.1 18 0.0 -1.7 16 138 126 17 15 57 4.2
15 -37 5.0 -6.8 9.9 2.0 113 17 -98 -11 -9.5 29
-3.4 -9.7 -14 -10 -15 -14 -25 -65 -104 -72 -45 7.6

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?